[144] United Therapeutics Corp SEC Filing
United Therapeutics Corp (UTHR) filing a Form 144 notifies a proposed sale of 3,000 common shares on 09/02/2025 through Morgan Stanley Smith Barney LLC on NASDAQ with an aggregate market value of $1,269,630.00. The shares were acquired the same day by stock option exercise and paid in cash. The filer reports no securities sold in the past three months and affirms they are unaware of undisclosed material adverse information. The notice includes standard Rule 144 and 10b5-1 representations.
United Therapeutics Corp (UTHR) ha presentato un modulo 144 per notificare la prevista vendita di 3.000 azioni ordinarie il 02/09/2025 tramite Morgan Stanley Smith Barney LLC su NASDAQ, per un valore complessivo di mercato di $1.269.630,00. Le azioni sono state acquisite lo stesso giorno mediante esercizio di opzioni su azioni e pagate in contanti. Il dichiarante segnala di non aver venduto titoli nei tre mesi precedenti e conferma di non essere a conoscenza di informazioni materiali avverse non divulgate. L鈥檃vviso contiene le dichiarazioni standard previste dalla Rule 144 e dalla 10b5-1.
United Therapeutics Corp (UTHR) present贸 un Formulario 144 notificando la propuesta venta de 3.000 acciones ordinarias el 02/09/2025 a trav茅s de Morgan Stanley Smith Barney LLC en NASDAQ, con un valor de mercado agregado de $1.269.630,00. Las acciones se adquirieron el mismo d铆a mediante ejercicio de opciones sobre acciones y se pagaron en efectivo. El declarante informa no haber vendido valores en los 煤ltimos tres meses y afirma no tener conocimiento de informaci贸n material adversa no divulgada. El aviso incluye las representaciones est谩ndar de la Rule 144 y la 10b5-1.
United Therapeutics Corp (UTHR)電� Form 144毳� 鞝滌稖頃橃棳 NASDAQ鞐愳劀 Morgan Stanley Smith Barney LLC毳� 韱淀暣 2025-09-02鞐� 3,000 氤错喌欤茧ゼ 毵る弰頃� 鞓堨爼鞛勳潉 韱奠頄堨溂氅�, 齑� 鞁滉皜齑濎暋鞚� $1,269,630.00鞛呺媹雼�. 頃措嫻 欤检嫕鞚� 臧欖潃 雮� 鞀ろ啞 鞓奠厴 頄夓偓搿� 旆摑霅橃棃瓿� 顺勱笀鞙茧 歆�旮夒悩鞐堨姷雼堧嫟. 鞝滌稖鞚胳潃 歆�雮� 3臧滌洈 霃欖晥 毵る弰頃� 歃濌秾鞚� 鞐嗢潓鞚� 氤搓碃頃橁碃, 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 鞎岇 氇豁暅雼り碃 頇曥澑頃╇媹雼�. 韱奠靹滌棎電� Rule 144 氚� 10b5-1鞚� 響滌 歆勳垹鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟.
United Therapeutics Corp (UTHR) a d茅pos茅 un Formulaire 144 pour notifier la vente projet茅e de 3 000 actions ordinaires le 02/09/2025 via Morgan Stanley Smith Barney LLC sur le NASDAQ, pour une valeur de march茅 totale de 1 269 630,00 $. Les actions ont 茅t茅 acquises le m锚me jour par exercice d鈥檕ptions sur actions et pay茅es en 别蝉辫猫肠别蝉. Le d茅clarant indique n鈥檃voir vendu aucun titre au cours des trois derniers mois et affirme n鈥檃voir connaissance d鈥檃ucune information d茅favorable mat茅rielle non divulgu茅e. L鈥檃vis comprend les repr茅sentations standard pr茅vues par la Rule 144 et la 10b5-1.
United Therapeutics Corp (UTHR) hat ein Formular 144 eingereicht und damit den geplanten Verkauf von 3.000 Stammaktien am 02.09.2025 眉ber Morgan Stanley Smith Barney LLC an der NASDAQ mit einem aggregierten Marktwert von $1.269.630,00 angek眉ndigt. Die Aktien wurden am selben Tag durch Aus眉bung von Aktienoptionen erworben und in Bargeld bezahlt. Der Meldende gibt an, in den letzten drei Monaten keine Wertpapiere verkauft zu haben, und best盲tigt, keine nicht offengelegten wesentlichen nachteiligen Informationen zu kennen. Die Mitteilung enth盲lt die 眉blichen Zusicherungen gem盲脽 Rule 144 und 10b5-1.
- None.
- None.
Insights
TL;DR: Routine insider sale notice following option exercise; procedural compliance appears intact.
The Form 144 documents a same-day stock option exercise and immediate proposed sale of 3,000 common shares with an aggregate market value of $1,269,630. The use of a broker and the filing of Form 144 indicate the filer intends to comply with Rule 144 resale requirements. No prior sales in the past three months are reported, reducing aggregation concerns. There is no disclosure of undisclosed adverse information and no indication of a trading plan date for Rule 10b5-1 in the visible fields.
TL;DR: Procedural disclosure only; no material governance or control change disclosed.
The filing is limited to disclosure of a proposed sale following an option exercise. It does not show leadership changes, related-party transactions beyond the option exercise, or other governance actions. The representation about lack of material undisclosed information is standard. Investors receive a clear notice of insider selling activity, but the filing contains no additional corporate governance signals.
United Therapeutics Corp (UTHR) ha presentato un modulo 144 per notificare la prevista vendita di 3.000 azioni ordinarie il 02/09/2025 tramite Morgan Stanley Smith Barney LLC su NASDAQ, per un valore complessivo di mercato di $1.269.630,00. Le azioni sono state acquisite lo stesso giorno mediante esercizio di opzioni su azioni e pagate in contanti. Il dichiarante segnala di non aver venduto titoli nei tre mesi precedenti e conferma di non essere a conoscenza di informazioni materiali avverse non divulgate. L鈥檃vviso contiene le dichiarazioni standard previste dalla Rule 144 e dalla 10b5-1.
United Therapeutics Corp (UTHR) present贸 un Formulario 144 notificando la propuesta venta de 3.000 acciones ordinarias el 02/09/2025 a trav茅s de Morgan Stanley Smith Barney LLC en NASDAQ, con un valor de mercado agregado de $1.269.630,00. Las acciones se adquirieron el mismo d铆a mediante ejercicio de opciones sobre acciones y se pagaron en efectivo. El declarante informa no haber vendido valores en los 煤ltimos tres meses y afirma no tener conocimiento de informaci贸n material adversa no divulgada. El aviso incluye las representaciones est谩ndar de la Rule 144 y la 10b5-1.
United Therapeutics Corp (UTHR)電� Form 144毳� 鞝滌稖頃橃棳 NASDAQ鞐愳劀 Morgan Stanley Smith Barney LLC毳� 韱淀暣 2025-09-02鞐� 3,000 氤错喌欤茧ゼ 毵る弰頃� 鞓堨爼鞛勳潉 韱奠頄堨溂氅�, 齑� 鞁滉皜齑濎暋鞚� $1,269,630.00鞛呺媹雼�. 頃措嫻 欤检嫕鞚� 臧欖潃 雮� 鞀ろ啞 鞓奠厴 頄夓偓搿� 旆摑霅橃棃瓿� 顺勱笀鞙茧 歆�旮夒悩鞐堨姷雼堧嫟. 鞝滌稖鞚胳潃 歆�雮� 3臧滌洈 霃欖晥 毵る弰頃� 歃濌秾鞚� 鞐嗢潓鞚� 氤搓碃頃橁碃, 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 鞎岇 氇豁暅雼り碃 頇曥澑頃╇媹雼�. 韱奠靹滌棎電� Rule 144 氚� 10b5-1鞚� 響滌 歆勳垹鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟.
United Therapeutics Corp (UTHR) a d茅pos茅 un Formulaire 144 pour notifier la vente projet茅e de 3 000 actions ordinaires le 02/09/2025 via Morgan Stanley Smith Barney LLC sur le NASDAQ, pour une valeur de march茅 totale de 1 269 630,00 $. Les actions ont 茅t茅 acquises le m锚me jour par exercice d鈥檕ptions sur actions et pay茅es en 别蝉辫猫肠别蝉. Le d茅clarant indique n鈥檃voir vendu aucun titre au cours des trois derniers mois et affirme n鈥檃voir connaissance d鈥檃ucune information d茅favorable mat茅rielle non divulgu茅e. L鈥檃vis comprend les repr茅sentations standard pr茅vues par la Rule 144 et la 10b5-1.
United Therapeutics Corp (UTHR) hat ein Formular 144 eingereicht und damit den geplanten Verkauf von 3.000 Stammaktien am 02.09.2025 眉ber Morgan Stanley Smith Barney LLC an der NASDAQ mit einem aggregierten Marktwert von $1.269.630,00 angek眉ndigt. Die Aktien wurden am selben Tag durch Aus眉bung von Aktienoptionen erworben und in Bargeld bezahlt. Der Meldende gibt an, in den letzten drei Monaten keine Wertpapiere verkauft zu haben, und best盲tigt, keine nicht offengelegten wesentlichen nachteiligen Informationen zu kennen. Die Mitteilung enth盲lt die 眉blichen Zusicherungen gem盲脽 Rule 144 und 10b5-1.
FAQ
What did United Therapeutics (UTHR) disclose in this Form 144?
How were the UTHR shares acquired that are being sold?
Did the filer report any securities sold in the past three months?
Through which broker will the UTHR shares be sold and on which exchange?
Does the filing indicate any undisclosed material information about United Therapeutics?
